Media Doctor Canada
Follow us on Twitter








"Statins cut heart risks even in healthy patients"


Source: CTV.CA

Published: 02 Jul 2022

Category: Pharmaceutical

Rating: (1 star)

Keywords: statins cholesterol

what they said (Hover the mouse cursor over underlined words for more info)

Even people who do not have high cholesterol and established heart disease could benefit from cholesterol-lowering statin drugs if they have other risk factors, a new study suggests.

In an analysis published on, researchers reviewed 10 studies that followed more than 70,000 patients. They conclude that statins, such as Lipitor and Zocor, should be given to anyone who is at risk of heart disease, including those with high blood pressure and diabetes...

The original article can be found at:

how did it rate? (more information)

Criteria Rating
Total Score 2 of 10
Availability of Treatment Not Satisfactory (?)
Novelty of Treatment Satisfactory (?)
Disease Mongering Satisfactory (?)
Treatment Options Not Satisfactory (?)
Costs of Treatment Not Satisfactory (?)
Evidence Not Satisfactory (?)
Quantification of Benefits of Treatment Not Satisfactory (?)
Harms of Treatment Not Satisfactory (?)
Sources of Information Not Satisfactory (?)
Relies on Press Release Not Applicable
Quantification of Harms of Treatment Not Satisfactory (?)

what we said (Hover the mouse cursor over underlined words for more info)

Conducting a meta-analsysis (combining research study data from several studies together) is highly complex, and can lead to extremely misleading conclusions. Merely stating that "differences in study design and quality were taken into account" is an insufficient statement regarding this critical issue. This is a particular concern because nothing is disclosed about the funding of this study and possible conflicts of interest. For example, the objective of this "research" could be to expand the pharmaceutical company market for statins into healthy patient populations.

Furthermore, not disclosing more about safety issues when there is a long history of safety concerns with statins in all patient populations (not just in a few types of patients) discredits this article as well. Their wording is quite subtle. Saying that there were no differences "in treatment" between patient populations does not say if there were differences in adverse events. Saying that there was not an increased risk of cancer is the only statement about adverse events, and a very superficial one at that. For example, there could have been many deaths with the statin treatment, but not an increased risk of cancer (which often wouldn't be noticed after only four years at that - the length of this analysis).

public forum

voice your opinion in the forum

  • All comments and feedback submitted to Media Doctor are subject to editorial approval before being made viewable by the public. It may take up to a week for your comments to be approved. Additionally, no response will be given to questions posed in public comments. Media Doctor does not provide medical advice, or answers to medical questions posed by the public.
  • If you provide your email address it will not be displayed to the general public.
  • Comments may be edited by Media Doctor to remove defamatory or sensitive statements, and brand names.
  • Required fields are marked with an asterisk (*).
Name: *
Comments: *
Copyright © Media Doctor Canada